Chronic substance use disorders Addiction
Conditions
Interventions
Participating patients will receive CM as an addition to CRA treatment (Treatment As Usual, TAU). Before CM begins, a baseline phase of three to five weeks will take place, during which patients conti
Sponsors
IrisZorg
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, patients must meet the following criteria:A DSM-5 classification of substance use,Receiving CRA during the baseline and intervention phaseBeing treated by one of the FACT-teams of IrisZorg,Age 18+, Sufficient Dutch language proficiency,Written informed consent.In order to be eligible to participate in this study, a participating therapist must meet the following criteria:Completed CRA certification,Completed CM training,Working in a FACT-team,Working with adult patients,Written informed consent.
Exclusion criteria
Exclusion criteria: If any of the following criteria are met, patients will be excluded from participation in this study:Severe psychiatric symptoms: Patients exhibiting manic, psychotic, suicidal, or aggressive behaviors that could pose a danger to themselves or others, or significantly affect their ability to adhere to the study. The presence of severe symptoms will be evaluated by a general mental health psychologist, clinical psychologist, psychiatrist, or addiction physician. This screening is conducted by the primary therapist before enrollment.Primary diagnosis of gambling disorder: Patients whose main diagnosis is a gambling disorder will not be included.Limited Dutch language proficiency: Patients who do not have sufficient command of the Dutch language to follow instructions, communicate effectively, or engage meaningfully in the intervention.No access to a smartphone: Patients must have a smartphone to use the m-Path app for self-registration and participation. Those without access to a smartphone will be excluded. There are no exclusion criteria for participating therapist.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is the change in prosocial behavior from the start of the baseline phase to the end of the intervention phase. To objectively measure this change, daily assessments will be conducted, starting in the baseline phase and continuing throughout the intervention. Patients will self-register their prosocial activities each day, allowing for a continuous record of progress. Additional repeated assessments will take place at T0, T1, T2 and T3. | — |
Secondary
| Measure | Time frame |
|---|---|
| Facilitators and barriers (i.e., intervention feasibility) will be described qualitatively. | — |
Countries
Netherlands
Contacts
Public ContactW. Markus
IrisZorg
Outcome results
None listed